Microangiopathic hemolytic anemia pathophysiology
|
Microangiopathic hemolytic anemia Microchapters |
|
Differentiating Microangiopathic hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Microangiopathic hemolytic anemia pathophysiology On the Web |
|
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia pathophysiology |
|
Microangiopathic hemolytic anemia pathophysiology in the news |
|
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
|
Risk calculators and risk factors for Microangiopathic hemolytic anemia pathophysiology |
Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
Pathophysiology
- It is thought that microangiopathic hemolytic anemia is mediated by endothelial injury, platelet activation, microthrombi formation, intra-vascular hemolysis and thrombocytopenia.
- In diseases such as hemolytic uremic syndrome, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, as well as malignant hypertension, the endothelial layer of small vessels are damaged with resulting fibrin deposition and platelet aggregation.
- The mechanism of endothelial injury varies depending on the underlying cause. It results in platelets aggregation and activation the coagulation cascade. There is the formation of a fibrin mesh due to increased activity of coagulation cascade.
- This results in the formation of microthrombi in the [[blood vessel] and reduction of the caliber of the blood vessels.
- The red blood cells are fragmented due to mechanical sheering by the microthrombi.
Microscopic Pathology
The red blood cells are physically cut by these protein networks, and the fragments are identical to the schistocytes seen on light microscopy.